Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
CALL
Applied Materials
AMAT
$294B
| $115M | 0.09% |
224,700
+72,000
| +47% | +$36.6M |
2023 Q3
12 quarters
|
|
252
CALL
TSMC
TSM
$2.07T
| $115M | 0.09% |
251,600
+134,400
| +115% | +$56.9M |
2024 Q1
10 quarters
|
|
253
Colgate-Palmolive
CL
$79.2B
| $115M | 0.09% |
1,344,878
+675,612
| +101% | +$61.1M |
2024 Q3
8 quarters
|
|
254
Public Service Enterprise Group
PEG
$37.8B
| $114M | 0.09% |
1,696,903
+957,792
| +130% | +$71.9M |
2025 Q1
6 quarters
|
|
255
Stryker
SYK
$118B
| $114M | 0.09% |
+414,205
| New | +$130M |
2026 Q3
0 quarters
|
|
256
SPX Corp
SPXC
$7.76B
| $113M | 0.09% |
667,612
+655,922
| +5,611% | +$133M |
2026 Q2
1 quarter
|
|
257
Insmed
INSM
$26.6B
| $113M | 0.09% |
987,459
-694,875
| -41% | -$81.9M |
2026 Q1
2 quarters
|
|
258
BP
BP
$118B
| $112M | 0.09% |
2,549,542
-520,700
| -17% | -$22.3M |
2025 Q1
6 quarters
|
|
259
PUT
Marvell Technology
MRVL
$141B
| $111M | 0.09% |
421,700
+60,900
| +17% | +$13.7M |
2023 Q3
12 quarters
|
|
260
Okta
OKTA
$32B
| $111M | 0.09% |
+531,574
| New | +$84.2M |
2026 Q3
0 quarters
|
|
261
CoStar Group
CSGP
$12.5B
| $111M | 0.09% |
4,056,346
+837,977
| +26% | +$25.2M |
2026 Q2
1 quarter
|
|
262
Planet Labs
PL
$5.02B
| $111M | 0.09% |
6,777,779
+6,769,823
| +85,091% | +$145M |
2026 Q2
1 quarter
|
|
263
W.W. Grainger
GWW
$69.7B
| $111M | 0.09% |
+89,007
| New | +$117M |
2026 Q3
0 quarters
|
|
264
Tradeweb Markets
TW
$27.8B
| $111M | 0.09% |
1,099,393
+270,739
| +33% | +$27.8M |
2023 Q2
13 quarters
|
|
265
ConocoPhillips
COP
$168B
| $111M | 0.09% |
884,451
-1,762,666
| -67% | -$218M |
2026 Q1
2 quarters
|
|
266
Charles River Laboratories
CRL
$16.2B
| $111M | 0.09% |
375,045
+359,175
| +2,263% | +$94.7M |
2026 Q2
1 quarter
|
|
267
British American Tobacco
BTI
$133B
| $111M | 0.09% |
2,033,624
+1,110,245
| +120% | +$64.4M |
2024 Q3
8 quarters
|
|
268
Brinker International
EAT
$8.24B
| $110M | 0.09% |
570,065
+483,308
| +557% | +$102M |
2026 Q2
1 quarter
|
|
269
Mettler-Toledo International
MTD
$34.6B
| $110M | 0.09% |
+72,886
| New | +$101M |
2026 Q3
0 quarters
|
|
270
PUT
Eli Lilly
LLY
$1.29T
| $110M | 0.09% |
94,900
-8,800
| -8% | -$10.4M |
2023 Q2
13 quarters
|
|
271
TXNM Energy Inc
TXNM
$6.48B
| $109M | 0.09% |
1,877,154
-207,099
| -10% | -$11.9M |
2025 Q2
5 quarters
|
|
272
CALL
CrowdStrike
CRWD
$232B
| $109M | 0.09% |
412,800
-136,000
| -25% | -$28.9M |
2023 Q3
12 quarters
|
|
273
Broadridge
BR
$21.8B
| $109M | 0.09% |
674,619
-638,523
| -49% | -$104M |
2024 Q1
10 quarters
|
|
274
Qnity Electronics Inc
Q
$24.7B
| $108M | 0.09% |
862,524
+339,713
| +65% | +$44.5M |
2025 Q4
3 quarters
|
|
275
Loews
L
$22.6B
| $108M | 0.09% |
1,036,540
+814,160
| +366% | +$91.2M |
2026 Q1
2 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.